| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |